Local Anesthetics Series  ·  Module 4 of 4
Systemic Toxicity, Methemoglobinemia, and Special Considerations
Toxicity progression, lipid emulsion rescue, methemoglobinemia, and special populations
Systemic Local Anesthetic Toxicity — Progression and Treatment
Toxicity Sequence
Central Nervous System Then Cardiovascular
  • Early (low concentration): circumoral and tongue numbness, tinnitus, metallic taste
  • Agitation, confusion, slurred speech
  • Muscle twitching → generalized seizures
  • Later (high concentration): PR prolongation, QRS widening, ventricular arrhythmias
  • Myocardial depression → cardiac arrest
Treatment
Stop — Airway — Seizures — Lipid
  • Stop injection immediately at first sign
  • Secure airway; 100% oxygen
  • Seizures: benzodiazepines preferred (avoid large propofol doses)
  • Intravenous lipid emulsion (20%) for severe toxicity — "lipid sink" mechanism
  • Bupivacaine arrest: prolonged resuscitation — do not give up early
Bupivacaine Cardiotoxicity — High Yield
"Fast in, slow out" from cardiac sodium channels. Drug accumulates with each heartbeat. Cardiac arrest extremely difficult to resuscitate. Lipid emulsion is the specific treatment. Never use bupivacaine for intravenous regional anesthesia (Bier block).
Methemoglobinemia
Mechanism, Presentation, Treatment
Oxidation of Hemoglobin Iron — Ferrous to Ferric
Aspect Details High-yield fact
Mechanism Hemoglobin iron oxidized from ferrous (Fe2+) to ferric (Fe3+) — cannot carry oxygen Prilocaine: metabolite ortho-toluidine. Benzocaine: topical sprays (endoscopy)
Presentation Cyanosis not responding to supplemental oxygen; dark chocolate-brown blood Pulse oximetry reads approximately 85% regardless of true saturation — unreliable; confirm with co-oximetry
Treatment Methylene blue 1 to 2 mg/kg intravenously — reduces methemoglobin via NADPH-methemoglobin reductase pathway Glucose-6-phosphate dehydrogenase deficiency: methylene blue FAILS — use ascorbic acid instead
Special Populations
Liver Disease
Impaired Amide Metabolism
  • Amide local anesthetics depend on hepatic metabolism
  • Liver disease reduces clearance → higher plasma levels
  • Reduce dose; consider ester agents as alternative
  • Ester agents (plasma metabolism) unaffected by liver disease
Pseudocholinesterase Deficiency
Impaired Ester Metabolism
  • Ester local anesthetics require plasma pseudocholinesterase
  • Deficiency prolongs duration and increases toxicity risk
  • Use amide local anesthetics instead
  • Amide metabolism (hepatic) unaffected
Pregnancy
Ion Trapping in Fetus
  • All local anesthetics cross the placenta
  • Lower fetal pH shifts drug toward ionized form in fetal tissue
  • Ionized form cannot cross back → drug trapped in fetus
  • Use lowest effective concentration; bupivacaine and ropivacaine preferred for obstetric epidural
Lipid Emulsion — Must Be Available
20% intravenous lipid emulsion must be immediately stocked wherever regional anesthesia is performed. For bupivacaine cardiac arrest: do not give up early — prolonged resuscitation plus lipid emulsion can achieve recovery of spontaneous circulation.